The infusion patient population is evolving, with shifts that include:

• More patients needing non-oncology infusions for specialties like rheumatology and gastroenterology.
• More patients receiving complex drug regimens like CAR T-cell therapies and bispecific antibodies as treatment moves from the inpatient setting into outpatient infusion centers.
• More patients with acute care needs as health systems reduce length of stay by moving patients from inpatient to outpatient settings.